| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 01/12/2021 | 08:00 | GlobeNewswire Inc. | OKYO Pharma Limited: Directorate Change | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 02/05/2019 | 16:58 | Edgar (US Regulatory) | Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ... | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 02/05/2019 | 16:31 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 06/03/2019 | 15:30 | PR Newswire (US) | Synergy Pharmaceuticals Announces Completion of Sale to Bausch Health | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 06/03/2019 | 15:00 | PR Newswire (Canada) | Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc. | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 02/03/2019 | 01:13 | Dow Jones News | Synergy Pharmaceuticals Is Approved to Sell Assets to Bausch Health | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 02/03/2019 | 00:30 | PR Newswire (US) | Synergy Pharmaceuticals Receives Court Approval for the Sale of Its Assets to Bausch Health | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 27/02/2019 | 01:07 | Dow Jones News | Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc. | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 27/02/2019 | 00:00 | PR Newswire (US) | Synergy Pharmaceuticals Confirms Bausch Health as Successful Bidder for Its Business Assets | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 12/02/2019 | 18:53 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 17/12/2018 | 21:43 | Dow Jones News | Synergy Pharmaceuticals Up 55% on Trulance Progress in Canada | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 12/12/2018 | 17:10 | Dow Jones News | Former Pharma Highflier Appreciates Bathroom Humor -- Overheard | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 12/12/2018 | 14:18 | Dow Jones News | Bausch Health to Buy Synergy Pharmaceuticals Out of Bankruptcy for $200 Million--Update | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 12/12/2018 | 13:14 | Dow Jones News | Bausch Health Agrees to Buy Synergy Pharmaceuticals for $200 Million | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 12/12/2018 | 12:30 | PR Newswire (US) | Bausch Health Enters Into Definitive "Stalking Horse" Agreement To Acquire Substantially All The Assets Of Synergy Pharmaceut... | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 12/12/2018 | 12:00 | PR Newswire (US) | Synergy Pharmaceuticals Announces Agreement for Bausch Health to Acquire Its Business Assets | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 15/11/2018 | 18:33 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 09/11/2018 | 15:09 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 08/11/2018 | 23:00 | Business Wire | Synergy Pharmaceuticals Reports Third Quarter 2018 Financial Results and Business Update | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 31/10/2018 | 22:00 | Business Wire | Synergy Pharmaceuticals Names Dr. Melvin K. Spigelman Chairman | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 25/10/2018 | 23:00 | Business Wire | Synergy Pharmaceuticals Provides Business Update | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 08/10/2018 | 14:00 | Business Wire | Synergy Pharmaceuticals Presents New Analyses Supporting the Use of TRULANCE® (plecanatide) in Two Patient Populations at th... | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 01/10/2018 | 15:30 | Business Wire | Synergy Pharmaceuticals to Present New Analyses of TRULANCE® (Plecanatide) at the American College of Gastroenterology (ACG)... | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 24/09/2018 | 14:00 | Business Wire | Synergy Pharmaceuticals Strengthens Coverage for TRULANCE® (plecanatide) with Key New Market Access Wins | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 16/08/2018 | 23:03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 08/08/2018 | 03:22 | Business Wire | CORRECTING and REPLACING Synergy Pharmaceuticals Reports Second Quarter 2018 Financial Results and Business Update | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 07/08/2018 | 23:00 | Business Wire | Synergy Pharmaceuticals Reports Second Quarter 2018 Financial Results and Business Update | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 07/08/2018 | 15:00 | Business Wire | Synergy Pharmaceuticals Announces TRULANCE® (plecanatide) Added to Express Scripts 2019 National Preferred Formulary List | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 07/08/2018 | 12:00 | Business Wire | Synergy Pharmaceuticals Announces License Agreement with Luoxin Pharmaceutical Group for TRULANCE® (plecanatide) in China | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |
| 13/06/2018 | 13:30 | Business Wire | Synergy Pharmaceuticals Announces Amendment to CRG Debt Agreement | NASDAQ:SGYP | Synergy Pharmaceuticals, Inc. |